reference/24104100

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24104100

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	52
issn	1524-4563 0194-911X
issueIdentifier	1
pageRange	46-52
publicationName	Hypertension (Dallas, Tex. : 1979)
startingPage	46
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_327ad0da5f93cf6108d59b85c6ea7829
bibliographicCitation	Kizer JR, Dahlöf B, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Wachtell K, Edelman JM, Snapinn SM, Harris KE, Devereux RB. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study. Hypertension. 2005 Jan;45(1):46–52. doi: 10.1161/01.hyp.0000151324.05355.1c. PMID: 15583076.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6753dbdd59236ed07f4e53cf2156270 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db834f06a06565325d7caa698c596f78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9248e7d38b3b2078a6d8d7d374344fc7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a706cd3f0f8541f7cbc1f021e36a4a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9e0ad725a8b467af6040005e03425f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb71168ae4d0d71cb6b1623ac7208d91 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29ac787fa7ab28f01c2d6b9d639a152f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cfbfa9ef3df777d4e88b9c4e8026b21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b965639c24e01c0ac75fc97771731ce4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f9950901fcfd8d6aca588c77e55384a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54f077cf050cb5a42ad2debc1af37e0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ebb78cacdb67f1606514cb6bc0e7ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_364894b88f1aae9b6847d8b81499dcfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f658fe92148f1fba2768147da42e786 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_301de199edce2756c2e7104e18ceafe6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaa9c2f94802401a2781faafdbed4601 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f2398e146d6307a8edd6387bb47cf08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d53d27888137d8a3fd268d987f35c21 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58b94e3885f188061d905723846fd1ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_071b6ee5d4f87818ea0c018bfb88dd68
date	200501
identifier	https://pubmed.ncbi.nlm.nih.gov/15583076 https://doi.org/10.1161/01.hyp.0000151324.05355.1c
isPartOf	https://portal.issn.org/resource/ISSN/1524-4563 https://portal.issn.org/resource/ISSN/0194-911X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4217
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study
discusses	http://id.nlm.nih.gov/mesh/M0456879 http://id.nlm.nih.gov/mesh/M0001900 http://id.nlm.nih.gov/mesh/M0029400 http://id.nlm.nih.gov/mesh/M0001456
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D020521Q000517 http://id.nlm.nih.gov/mesh/D000959Q000627 http://id.nlm.nih.gov/mesh/D006973Q000150 http://id.nlm.nih.gov/mesh/D001262Q000627 http://id.nlm.nih.gov/mesh/D019808Q000627 http://id.nlm.nih.gov/mesh/D017379Q000150 http://id.nlm.nih.gov/mesh/D047228Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006973Q000188 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D015897 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D001281Q000150 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D048909 http://id.nlm.nih.gov/mesh/D006937Q000150 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D015994 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D020521Q000453
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c32c0d8aa4f785d63c80f6f9c7c6be06 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6748 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8652 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6994 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10017 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7224 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585206 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961263

Total number of triples: 83.